And just like that, stocks have landed back in the green. Following a several week long market performance that can only be described …
With the number of global coronavirus infections now exceeding 93,000, Wall Street observers aren’t sure that monetary policy will be enough to limit …
Written by Daniel Cohen and Scott Matusow Lately, many early stage developmental biotech companies have been going on some seriously epic runs. Karuna …
In a previous article, I talked about the so-called patent cliff and the correlation to the pace of mergers and acquisitions in the pharma …
It’s a very rewarding trading day for investors in Trevena (TRVN) with shares up over 70%, making the stock Wall Street’s bull of …
Amarin (AMRN) has had a lot of attention over its fish oil pill Vascepa, which aims to help those with cardiovascular problems and …
Aphria (APHA) stock tests investor nerves in roller coaster ride following an announcement Thursday from U.S.
Canadian pharmaceutical company Tilray (TLRY) announced this week a partnership with beer and beverage giant Anheuser-Busch InBev to research cannabis beverages. The two companies will be investing …
Medical cannabis maker Tilray (TLRY) announced early Tuesday that it has entered into a global supply and distribution agreement for medical marijuana with …
It’s a new age, alright. Cannabis is becoming more normalized and companies are already capitalizing.
